Completed PHASE3 INTERVENTIONAL 2-arm NCT00746096

Efficacy and Safety Study of Low Dose Oral Contraceptive Pill to Treat Primary Dysmenorrhea

Phase 3, Placebo Controlled, Randomized, Double-blinded, Nonsteroidal Antiinflammatory Drug add-on Clinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Primary Dysmenorrhea.

Sponsor: Nobelpharma

Conditions Dysmenorrhea

Interventions IKH-01 Placebo

Updated 7 times since 2017 Last updated: Feb 18, 2025 Started: Sep 30, 2008 Primary completion: Sep 30, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00746096, this PHASE3 trial focuses on Dysmenorrhea and remains completed. Sponsored by Nobelpharma, it has been updated 7 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE3
Apr 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Apr 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nobelpharma

Data source: Nobelpharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.